comparison of two drugs for oral diseases that can be convert into cancer.
Phase 3
- Conditions
- Health Condition 1: O- Medical and SurgicalHealth Condition 2: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere
- Registration Number
- CTRI/2022/10/046681
- Lead Sponsor
- faculty of dental sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patient aged between 18-65 years of age
2.Patients suffering from DC/TMD diagnostic criteria for MPDS
3.Patients presenting with pain, trismus and clicking without any radiological and pathological findings.
Exclusion Criteria
1.Patient under the age of 18 and above 65 years
2.Patients with recent TMJ dislocation, hairy surface, radiculopathy, or other neurological deficits.
3.Patients on any medication for MPDS
4.Patients having any cardiac surgery or any other systemic illness.
5.Pregnancy or breastfeeding women
6.Patient diagnose with other orofacial pain disorders.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Reduction in the lesion area. <br/ ><br>Timepoint: baseline and after 4 weeks <br/ ><br>
- Secondary Outcome Measures
Name Time Method Changes in morphological aspects of the lesion will be assessed by orally examining before and after treatment (according to the Thongprasom score)Timepoint: baseline and after 4 weeks